These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20208492)

  • 21. New Parkinson's disease drug is available.
    Mayo Clin Health Lett; 1998 Aug; 16(8):4. PubMed ID: 9702132
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacogenetics in Parkinson's disease treatment].
    Białecka M; Kłodowska-Duda G; Kurzawski M; Droździk M
    Neurol Neurochir Pol; 2008; 42(2):131-8. PubMed ID: 18512170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.
    Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA
    Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New drug helps Parkinson's "off" periods.
    Health News; 2004 Jul; 10(7):2. PubMed ID: 15239150
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug for "off" episodes of Parkinson's--effective but limited.
    Mayo Clin Health Lett; 2005 Jul; 23(7):4. PubMed ID: 16189845
    [No Abstract]   [Full Text] [Related]  

  • 26. The future challenges in Parkinson's disease.
    Barker RA; Foltynie T
    J Neurol; 2004 Mar; 251(3):361-5. PubMed ID: 15015024
    [No Abstract]   [Full Text] [Related]  

  • 27. Drugs for Parkinson's Disease.
    Treat Guidel Med Lett; 2004 Jun; 2(22):41-6. PubMed ID: 15529113
    [No Abstract]   [Full Text] [Related]  

  • 28. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatments for Parkinson's disease.
    Health News; 2000 Jun; 6(6):8. PubMed ID: 10865523
    [No Abstract]   [Full Text] [Related]  

  • 30. Parkinson's disease. An overview of treatments and research.
    Tuite PJ
    Minn Med; 2001 May; 84(5):42-7. PubMed ID: 11398632
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment of Parkinson's disease].
    Bergmann S
    Timarit Hjukrunarfel Isl; 1975; 51(1):13-9. PubMed ID: 1039830
    [No Abstract]   [Full Text] [Related]  

  • 32. New drugs for Parkinson's disease.
    Med Lett Drugs Ther; 1976 Dec; 18(27):117-8. PubMed ID: 1004371
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug treatments and motor complications in advanced stage Parkinson's disease ].
    Marion MH
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():160-4. PubMed ID: 10916047
    [No Abstract]   [Full Text] [Related]  

  • 34. Deprenyl in Parkinson's disease.
    Korczyn AD; Nisipeanu P
    Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic indications in Parkinson's disease].
    Petit H
    LARC Med; 1983; 3(6):433-5. PubMed ID: 6888113
    [No Abstract]   [Full Text] [Related]  

  • 36. Acronyms: what's in a name?
    Friedman JH
    Med Health R I; 2009 Feb; 92(2):42. PubMed ID: 19288681
    [No Abstract]   [Full Text] [Related]  

  • 37. New pharmacological and surgical therapies for Parkinson's disease.
    Nutt JG
    West J Med; 1998 Apr; 168(4):267-8. PubMed ID: 9584671
    [No Abstract]   [Full Text] [Related]  

  • 38. Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease.
    Pirtosek Z; Merello M; Carlsson A; Stern G
    Adv Neurol; 1996; 69():535-40. PubMed ID: 8615177
    [No Abstract]   [Full Text] [Related]  

  • 39. New treatment for people with Parkinson's.
    FDA Consum; 2004; 38(4):5. PubMed ID: 15346564
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dangers in drug therapy of Parkinson's disease].
    Gehlen W
    Z Allgemeinmed; 1975 Nov; 51(33):1543-4. PubMed ID: 1210361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.